1

PathAI

AISight is a cloud-native digital pathology image management system supporting AI applications for case and image management, designed for leading laboratories and research centers.

paid

United States

2

Integrated Drug Creation

Absci is a clinical-stage biotechnology company that uses generative AI and a synthetic biology data engine to design antibody-based biologics against difficult-to-drug targets. It also combines AI models with high-throughput wet lab validation in iterative cycles for internal pipeline programs and partnerships.

N/A

unknown

United States

3

Juvenescence

Juvenescence develops innovative medicines targeting aging mechanisms to treat and prevent age-related diseases, enhancing healthy lifespan through AI-enabled R&D and adaptive clinical trials.

-1

unknown

United Kingdom

4

Healx

Healx leverages AI to transform drug discovery for rare diseases, enhancing known compounds and identifying novel drug-disease relationships to build effective therapies.

+1

unknown

United Kingdom

5

Anagenex

Anagenex accelerates drug discovery using proprietary generative AI and neural networks, processing billions of compound experiments to refine predictions and deliver medicines faster with datasets over 100B datapoints.

+1

paid

United States

6

NOETIK

Noetik leverages advanced machine learning to discover and develop cancer immunotherapies, focusing on precision and patient-centered approaches.

+2

unknown

United States

7

AQEMIA

Aqemia leverages quantum-inspired physics and AI to rapidly accelerate the drug discovery process, generating its own data to identify drug candidates with unprecedented speed and accuracy.

paid

France

8

Lantern Pharma

Lantern Pharma leverages AI, machine learning, and genomics to revolutionize oncology drug development, significantly enhancing speed, power, precision, and cost efficiency.

-4

paid

United States

9

Soley Therapeutics

Soley Therapeutics utilizes AI/ML to decode cellular language, enhancing drug discovery and development efficiency through a high-throughput platform technology.

-6

unknown

United States

10

Aignostics

Aignostics specializes in applying AI to precision medicine, transforming complex biomedical data to deliver insights that enhance drug development and patient outcomes. It integrates multimodal AI technologies with robust foundation models tailored for histopathology.

-1

unknown

Germany

11

GT Apeiron Therapeutics

Apeiron Therapeutics is a clinical-stage biopharmaceutical company developing biomarker-driven, AI-enabled small molecule therapies for cancer. The company leverages structure-based, AI-driven drug design to build a pipeline of targeted treatments, aiming for best-in-class and first-in-class oncology candidates that address unmet medical needs.

-1

unknown

United States

12

Athos Omics AI

Athos Therapeutics Inc. is a clinical-stage biotechnology company developing AI-based precision small molecule therapeutics for patients with inflammatory bowel disease and other autoimmune and chronic inflammatory diseases, integrating human clinical and molecular datasets with computational medicinal chemistry and machine learning. It also offers Athos Omics AI, a software platform for analyzing multi-omics data across industries such as drug, agriculture, food, beverage, and cosmetics development.

N/A

unknown

United States

13

GEn1E Lifesciences

GEn1E Lifesciences employs a machine learning-driven approach to accelerate the development of first-in-class therapies for inflammatory diseases, utilizing unique allosteric binding mechanisms to improve specificity and reduce side effects.

-2

paid

United States

14

Iktos

Makya is a generative AI platform by Iktos, designed for chemists to accelerate drug discovery using AI-driven molecular design, synthesis planning, and automation through a fully integrated pipeline.

-2

paid

France

15

Gero

Gero leverages physics-informed AI models to develop therapeutics targeting the root causes of aging, aiming to double human healthspan. Their platform integrates extensive real-world data to identify novel therapeutic targets and design effective interventions.

-2

unknown

United States

16

PhAST

PhAST Diagnostics uses AI and machine learning to enhance infectious disease diagnostics, focusing on antibiotic resistance with a cloud-based platform for clinical decision support and workflow improvement.

+4

unknown

United States

17

Recursion OS

Recursion Pharmaceuticals uses an AI-driven drug discovery platform to map biological and chemical relationships from cellular imaging and data, developing treatments for cancers and rare diseases. It also partners with biopharmaceutical and technology firms to identify novel therapeutic targets.

N/A

unknown

United States

18

RECEPTOR.AI

Receptor.AI accelerates drug discovery with AI-driven platforms for small molecules and peptides, integrating predictive modeling and data-driven strategies for efficient optimization.

-4

unknown

United Kingdom

19

Pattern Computer

Pattern Discovery Engine by Pattern Computer offers a transformative approach to data analytics by utilizing explainable AI for predictive insights and advanced hypothesis generation, catering to industries needing deep data-driven insights and innovative solutions.

N/A

paid

United States

20

CELLINK

CELLINK offers comprehensive 3D bioprinting solutions, including bioprinters and bioinks, to advance research in regenerative and personalized medicine and drug discovery.

-4

paid

Sweden

21

InpharmD

InpharmD™ provides healthcare professionals with quick access to customized, actionable drug information, enhancing efficiency in making informed clinical decisions by transforming complex literature searches into streamlined insights.

-6

paid

United States

22

bfLEAP

BullFrog AI Holdings, Inc. provides AI and machine learning software for pharmaceutical R&D, drug target discovery, and patient stratification. Its platform also includes capabilities for biology-aware data harmonization, causal AI analytics, and structured decision support with human-in-the-loop validation.

N/A

unknown

United States

23

Graphen

Graphen provides advanced AI solutions harnessing graph technology, offering AI-driven tools for finance, healthcare, and more, facilitating improved decision-making and operational efficiency through comprehensive data analysis.

-6

paid

United States

24

GenBio AI

GenBio AI develops AI-driven digital organisms using multiscale foundation models to predict, simulate, and program biology, advancing healthcare and scientific discovery.

-6

unknown

United States

25

Xaira

Xaira Therapeutics combines AI models with drug discovery and development, operating an integrated platform spanning target identification, molecule design, patient selection, and wet-lab experimentation. It also includes AI models, accelerators, and an AI-derived therapeutics pipeline.

N/A

unknown

United States